
The Federal Trade Commission (FTC) announced Tuesday that a firm once owned by “Pharma Bro” Martin Shkreli must pay a $40 million settlement due to bumping the price of medicine by about 4,000 percent. The life-saving drug, Daraprim, was owned exclusively by Shkreli’s formerly owned firm Vyera Pharmaceuticals LLC and... Read More »